Form 4: SERA CSO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


SERA Prognostics' Chief Scientific Officer, John J. Boniface, sold 7,094 shares of Class A Common Stock at a weighted average price of $2.54 to cover tax withholding obligations related to RSU vesting.

Summary

  • John J. Boniface, Chief Scientific Officer of SERA PROGNOSTICS, INC. (SERA), reported a transaction involving the company's Class A Common Stock.
  • On August 8, 2025, Mr. Boniface sold 7,094 shares.
  • The shares were sold at a weighted average price of $2.54 per share, with individual transactions ranging from $2.28 to $2.73.
  • This sale was not a discretionary transaction but was mandated by the Issuer's election to require 'sell to cover' transactions to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs).
  • Following this transaction, Mr. Boniface directly beneficially owns 160,888 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a non-discretionary 'sell to cover' transaction by an executive to satisfy tax obligations, which is a neutral event and does not reflect positively or negatively on the company's performance or outlook.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

  • The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by 'sell to cover' transactions and does not represent a discretionary transaction by the Reporting Person.

Industry Context

This Form 4 filing details a routine 'sell to cover' transaction by an executive, which is a common practice in the industry when restricted stock units (RSUs) vest. It does not indicate any specific industry trends or shifts, but rather reflects standard compensation and tax management practices for executives in publicly traded companies.

Stakeholder Impact

  • Shareholders: Minimal impact as the sale is non-discretionary and for tax purposes, not an indication of lack of confidence. It slightly increases the float but is a small percentage of outstanding shares.
  • Employees: No direct impact on employees, but it highlights the standard process for equity compensation and tax handling for executives.

Key Dates

DateDescription
08/08/2025Date of transaction (sale of shares).
08/11/2025Date the Form 4 was signed by the Reporting Person's attorney-in-fact.

Recommendation

hold

The filing details a non-discretionary 'sell to cover' transaction by a key executive to satisfy tax obligations upon RSU vesting. This is a routine event and does not reflect a change in management's confidence or the company's fundamentals, thus maintaining a neutral stance on the stock.

Keywords

SERA Prognostics, SERA, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Chief Scientific Officer, John J. Boniface

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.